Literature DB >> 7589888

Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?

E Cerasi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7589888     DOI： 10.1007/BF00400591

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  47 in total

1.  Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study.

Authors:  E Cerasi; R Luft; S Efendic
Journal:  Diabetes       Date:  1972-04       Impact factor: 9.461

Review 2.  Glucokinase as pancreatic beta cell glucose sensor and diabetes gene.

Authors:  F Matschinsky; Y Liang; P Kesavan; L Wang; P Froguel; G Velho; D Cohen; M A Permutt; Y Tanizawa; T L Jetton
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 3.  Why is insulin not a risk factor for coronary heart disease?

Authors:  R J Jarrett
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 4.  Why can high insulin levels indicate a risk for coronary heart disease?

Authors:  A Fontbonne
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 5.  Aspects of the pathogenesis of type 2 diabetes.

Authors:  S Efendić; R Luft; A Wajngot
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

Review 6.  Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion.

Authors:  J L Leahy; S Bonner-Weir; G C Weir
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

7.  Genetic regulation of the kinetics of glucose-induced insulin release in man. Studies in families with diabetic and non-diabetic probands.

Authors:  L Iselius; J Lindsten; N E Morton; S Efendić; E Cerasi; A Haegermark; R Luft
Journal:  Clin Genet       Date:  1985-07       Impact factor: 4.438

8.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

9.  Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.

Authors:  A Lorenzo; B Razzaboni; G C Weir; B A Yankner
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

10.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245
View more
  18 in total

1.  Characterization of the action of S 21403 (mitiglinide) on insulin secretion and biosynthesis in normal and diabetic beta-cells.

Authors:  Nurit Kaiser; Rafael Nesher; Andrei Oprescu; Suad Efendic; Erol Cerasi
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 2.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 3.  Targeting inflammation in the treatment of type 2 diabetes: time to start.

Authors:  Marc Y Donath
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

4.  Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance.

Authors:  A Mari; A Tura; A Natali; M Laville; M Laakso; R Gabriel; H Beck-Nielsen; E Ferrannini
Journal:  Diabetologia       Date:  2010-01-09       Impact factor: 10.122

5.  K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years.

Authors:  M Alvarsson; A Wajngot; E Cerasi; S Efendic
Journal:  Diabetologia       Date:  2005-09-14       Impact factor: 10.122

6.  Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Jan A Ehses; Zoltan Mathe; Domenico Bosco; Thierry Berney; Jean-Michel Dayer; Manfred Reinecke; Philippe A Halban; Marc Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

7.  Metabolic adaptations to chronic glucose infusion in rats.

Authors:  B G Topp; M D McArthur; D T Finegood
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

Review 8.  Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.

Authors:  Marc Y Donath; Joachim Størling; Kathrin Maedler; Thomas Mandrup-Poulsen
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

9.  Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men.

Authors:  K F Eriksson; F Lindgärde
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

10.  Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Jan A Ehses; Marc Y Donath; Thomas Mandrup-Poulsen
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.